← Leaderboards
Daniel Scott Wilbur
University Of Washington
$2,281,994
Attributed
$2,281,994
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $289.2K · FY2005–14$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$2,281,994 · 1
By mechanism
R01$2,281,994 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Allan Edward Rettie$24,434,501
- Kent L Kunze$2,654,464
- Gojko Lalic$1,882,096
- Daniel T Chiu$30,025,737
- Shaoyi Jiang$3,648,478
Others in their field
Top investigators on “Reagent”
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$239,426,049
- Lawrence Corey · Fred Hutchinson Cancer Center$239,426,049
- Timothy Stedman · American Type Culture Collection$135,545,770
- Stanley M Lemon · Univ Of North Carolina Chapel Hill$110,090,673
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$105,181,167
- Peter B. Gilbert · Fred Hutchinson Cancer Center$94,846,879
Research focus
ReagentIn VivoMalignant NeoplasmsBasePeptidesBoronFab ImmunoglobulinsLabelPropertySmall MoleculeChargeRadioisotopesBombesinAstatineDrug KineticsDrug Or Chemical Tissue DistributionBombesin AntagonistAnimalsBody WeightBlood Chemical AnalysisCouplingCancer PatientBloodCells
Grant awards (9)
Development of At-211-Labeled Reagents for Therapy of Metastatic Prostate Cancer$236,553
R01 · FY2014 · CA · contact PI
Development of At-211-Labeled Reagents for Therapy of Metastatic Prostate Cancer$229,372
R01 · FY2013 · CA · contact PI
Development of At-211-Labeled Reagents for Therapy of Metastatic Prostate Cancer$244,160
R01 · FY2012 · CA · contact PI
Development of At-211-Labeled Reagents for Therapy of Metastatic Prostate Cancer$244,311
R01 · FY2011 · CA · contact PI
Development of At-211-Labeled Reagents for Therapy of Metastatic Prostate Cancer$264,232
R01 · FY2010 · CA · contact PI
Development of Reagents for Labeling with At-211$255,505
R01 · FY2008 · CA · contact PI
Development of Reagents for Labeling with At-211$255,505
R01 · FY2007 · CA · contact PI
Development of Reagents for Labeling with At-211$263,137
R01 · FY2006 · CA · contact PI
Development of Reagents for Labeling with At-211$289,219
R01 · FY2005 · CA